TEM Latest Headlines

Tempus AI Raises 2026 Guidance and Returns to Profit—Sector Expectations Remain High

Market Chameleon (Mon, 10-Aug 9:21 AM)

Tempus Partnership Expands CellCarta’s Oncology Diagnostics Network—What This Means for CDx Commercialization

Market Chameleon (Thu, 6-Aug 9:47 AM)

PRISM2 Delivers Record-Setting Results in Cancer Diagnosis and Prognosis, Backed by 2.3 Million Pathology Images

Market Chameleon (Tue, 4-Aug 8:57 AM)

Tempus Delivers Standout Q2 with 22% Revenue Growth and $200M in New Data Licensing Deals

Market Chameleon (Fri, 31-Jul 7:10 AM)

TEM Expands Precision Oncology Capabilities with $1.5 Billion Personalis Acquisition

Market Chameleon (Mon, 20-Jul 8:32 AM)

Real-World Data Shows Tempus’ Paige Prostate AI Suite Enhances Diagnostic Precision and Efficiency in UK NHS

Market Chameleon (Thu, 16-Jul 8:35 AM)

Tempus AI’s Real Edge Lies in Its Proprietary Data Layer—What Sets TEM Apart in Life Sciences AI?

Market Chameleon (Wed, 1-Jul 9:21 AM)

Tempus’ Collaboration Creates Unprecedented Molecular Dataset for Rare Angiosarcoma Research

Market Chameleon (Thu, 25-Jun 9:46 AM)

Tempus AI's FDA-Cleared ECG Model Hits Milestone with Multi-Site Validation for Atrial Fibrillation Risk

Market Chameleon (Fri, 12-Jun 11:22 AM)

Tempus to Share AI-Powered Precision Medicine Advancements at Goldman Sachs Global Healthcare Conference

Market Chameleon (Mon, 8-Jun 7:32 AM)